BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Amicus Therapeutics (Nasdaq: FOLD) announced today that BioMarin has entered into a definitive agreement to acquire Amicus for $14.50 per share in an ...
Upon receipt of any formal director nominations from Altai, the Nominating and Corporate Governance Committee and OraSure’s Board will review them and present the Board’s recommendations to ...
Creating One of the Largest Omni-Channel Retailers Across the Full Inclusive Sizing Market, with Approximately $1.2 Billion of Combined Annual ...
The Vanguard Growth ETF has been a significant market beater. The Invesco QQQ Trust is heavily tech focused and can sometimes be volatile, but returns have been impressive. The Schwab U.S. Large-Cap ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Dividend growth stocks have a simple premise. Get low ...
Asia’s economic growth next year is poised to hold up more than previously estimated despite weaker external demand, elevated tariffs, and persistent policy uncertainty. Growth in the Asia and Pacific ...
Form3, the cloud-native global account-to-account payments infrastructure platform, today announces it has secured a strategic investment from Nationwide, the world’s largest building society, and a ...
This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. These investments will fund the company through to profitability by ...
WASHINGTON, Oct 13 (Reuters) - Surging business investment is expected to offset weaker growth in consumption and global trade and keep the U.S. economy growing near trend, according to a National ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Planning for retirement is critical whether you’re 25 and ...
Palantir continues to have a huge AI opportunity in front of it. AppLovin has been proving skeptics wrong and is embarking on its next phase of growth. GitLab is one of the most underrated growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results